6/7/2023  5:35:30 PM Chg. -91.00 Volume Bid5:46:01 PM Ask5:36:22 PM Market Capitalization Dividend Y. P/E Ratio
11,744.00GBX -0.77% 172,054
Turnover(GBP): 20.27 mill.
-Bid Size: - -Ask Size: - 182.59 bill.GBP - -

Business description

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Management board & Supervisory board

Pascal Soriot
Management board
Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Menelas (Mene) Pangalos, Jeff Pott, Iskra Reic, Leon Wang, Katarina Ageborg
Supervisory board
Leif Johansson, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Michel Demaré, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg

Company data

Name: AstraZeneca plc
Address: 1 Francis Crick Avenue Cambridge Biomedical Campus,Cambridge, CB2 0AA United Kingdom
Phone: +44-20-7604-8000
Fax: +44-20-7604-8151
E-mail: -
Internet: www.astrazeneca.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: -
IPO date: 4/6/1999

Investor relations

Name: Andy Barnett
IR phone: +44 (0)20 3749 5000
IR Fax: -
IR e-mail: CorporateAccess@astrazeneca

Main Shareholders

BlackRock, Inc
Wellington Management Company LLP
Wellington Management Group LLP
The Capital Group Companies, Inc.
Investor AB